Quarterly Metrics: Quick and Current Ratios for C4 Therapeutics Inc (CCCC)

For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

As of close of business last night, C4 Therapeutics Inc’s stock clocked out at $5.40, down -6.74% from its previous closing price of $5.79. In other words, the price has decreased by -$6.74 from its previous closing price. On the day, 0.58 million shares were traded. CCCC stock price reached its highest trading level at $5.8879 during the session, while it also had its lowest trading level at $5.285.

Ratios:

To gain a deeper understanding of CCCC’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.09 and its Current Ratio is at 5.09. In the meantime, Its Debt-to-Equity ratio is 0.28 whereas as Long-Term Debt/Eq ratio is at 0.25.

On December 13, 2023, Stifel Upgraded its rating to Buy which previously was Hold and also upped its target price recommendation from $2 to $12.

Credit Suisse Upgraded its Underperform to Neutral on February 24, 2023, whereas the target price for the stock was revised from $12 to $10.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CCCC now has a Market Capitalization of 374424128 and an Enterprise Value of 178742864. For the stock, the TTM Price-to-Sale (P/S) ratio is 12.74 while its Price-to-Book (P/B) ratio in mrq is 1.50. Its current Enterprise Value per Revenue stands at 6.084 whereas that against EBITDA is -1.559.

Stock Price History:

Over the past 52 weeks, CCCC has reached a high of $11.88, while it has fallen to a 52-week low of $1.06. The 50-Day Moving Average of the stock is 1.15%, while the 200-Day Moving Average is calculated to be -4.37%.

Shares Statistics:

It appears that CCCC traded 1.66M shares on average per day over the past three months and 1023540 shares per day over the past ten days. A total of 60.47M shares are outstanding, with a floating share count of 58.73M. Insiders hold about 15.30% of the company’s shares, while institutions hold 75.94% stake in the company. Shares short for CCCC as of 1721001600 were 11625527 with a Short Ratio of 6.30, compared to 1718323200 on 14543242. Therefore, it implies a Short% of Shares Outstanding of 11625527 and a Short% of Float of 20.580000000000002.

Most Popular